Publication | Closed Access
Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028
269
Citations
30
References
2018
Year
Advanced Ovarian CancerMedicineImmunologyTumor ImmunityPathologyCell DeathImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1